I’ve just returned from Beirut, where I had the privilege of attending the Future Health conference. My panel was titled, “Value Innovation for the Patient, the Healthcare Ecosystem, and the Economy. I was doubly honored that one of my co-panelists was Mr. Ghassan Hasbani, Lebanon’s Deputy Prime Minister and Minister of Health.
Minister Hasbani is revamping the medicines tendering program for Lebanon and one of the key tenets being weighed in the new national decision-making process is value. As His Excellency said from the podium, “It’s not only a cost, it’s an investment.”
Bravo.
And, as with any investment, it’s impossible to understand the cost without proper consideration of the return.
Minister Hasbani is revamping the medicines tendering program for Lebanon and one of the key tenets being weighed in the new national decision-making process is value. As His Excellency said from the podium, “It’s not only a cost, it’s an investment.”
Bravo.
And, as with any investment, it’s impossible to understand the cost without proper consideration of the return.
